PPBT
Purple BiotechNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.44M
P/E Ratio
0.00
EPS
$3226.00
Beta
-0.54
52W High
$29.00
52W Low
$1.42
50-Day MA
$3.77
200-Day MA
$6.05
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Purple Biotech
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. The company is headquartered in Rehovot, Israel.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | -59,000 |
| EBITDA | $-7.80M |
| Operating Margin | 0.00% |
| Return on Equity | -123.40% |
| Return on Assets | -19.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $10.00 |
| Price-to-Book | 0.14 |
| Price-to-Sales (TTM) | 58.08 |
| EV/Revenue | 33.07 |
| EV/EBITDA | -0.15 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 932,270 |
| Float | 925,480 |
| % Insiders | 5.97% |
| % Institutions | 10.49% |
Historical Volatility
HV 10-Day
58.97%
HV 20-Day
94.39%
HV 30-Day
83.65%
HV 60-Day
83.90%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($30.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026